A combined 3D QSAR and pharmacophore-based virtual screening for the identification of potent p38 MAP kinase inhibitors: an in silico approach

Abstractp38 kinase plays a vital role in inflammation mediated by tumor necrosis factor-α and interleukin-1β pathways. Inhibition of p38 kinase provides an effective way to treat inflammatory diseases. 3D-QSAR study was performed to obtain reliable comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) models for a series of p38 inhibitors with three different alignment methods (Receptor based, atom by atom matching, and pharmacophore based). Among the different alignment methods, better statistics were obtained with receptor-based alignment (CoMFA: q2 = 0.777, r2 = 0.958; CoMSIA: q2 = 0.782, r2 = 0.927). Superposing CoMFA/CoMSIA contour maps on the p38 active site gave a valuable insight to understand physical factors which are important for binding. In addition, this pharmacophore model was used as a 3D query for virtual screening against NCI database. The hit compounds were further filtered by docking and scoring, and their biological activities were predicted by CoMFA and CoMSIA models.

[1]  M. Feldmann,et al.  Cytokines and anti-cytokine biologicals in autoimmunity: present and future. , 2002, Cytokine & growth factor reviews.

[2]  D. E. Patterson,et al.  Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .

[3]  S. Wold.  Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .

[4]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[5]  Ajay N. Jain,et al.  Automatic identification and representation of protein binding sites for molecular docking , 1997, Protein science : a publication of the Protein Society.

[6]  A. Ghose,et al.  Atomic physicochemical parameters for three dimensional structure directed quantitative structure‐activity relationships III: Modeling hydrophobic interactions , 1988 .

[7]  S. Wold,et al.  The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .

[8]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[9]  Arup K. Ghose,et al.  Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..

[10]  Yvonne C. Martin,et al.  A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..

[11]  Andrew R. Leach,et al.  A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP , 2002, J. Comput. Aided Mol. Des..

[12]  E. Keystone,et al.  Restricted cytokine expression in rheumatoid arthritis. , 1993, Arthritis and rheumatism.

[13]  Robert Newton,et al.  Inhibitors of p38 Mitogen-Activated Protein Kinase , 2003, BioDrugs.

[14]  G. Klebe.  The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. , 1994, Journal of molecular biology.

[15]  T. Pincus.  Long-term outcomes in rheumatoid arthritis. , 1995, British journal of rheumatology.

[16]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[17]  Robert Newton,et al.  Inhibitors of p38 mitogen-activated protein kinase: potential as anti-inflammatory agents in asthma? , 2003, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[18]  P. Willett,et al.  A Comparison of Some Measures for the Determination of Inter‐Molecular Structural Similarity Measures of Inter‐Molecular Structural Similarity , 1986 .

[19]  G Klebe,et al.  Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. , 1999, Journal of medicinal chemistry.

[20]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[21]  Yong Jiang,et al.  Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ* , 1997, The Journal of Biological Chemistry.

[22]  Luping Liu,et al.  Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase. , 2003, Bioorganic & medicinal chemistry letters.

[23]  T. Pincus,et al.  Prognostic markers of activity and damage in rheumatoid arthritis: why clinical trials and inception cohort studies indicate more favourable outcomes than studies of patients with established disease. , 1995, British journal of rheumatology.

[24]  J Zhu,et al.  [Comparative molecular field analysis (CoMFA) of allylamine antimycotics]. , 1997, Yao xue xue bao = Acta pharmaceutica Sinica.

[25]  Jiahuai Han,et al.  The primary structure of p38 gamma: a new member of p38 group of MAP kinases. , 1996, Biochemical and biophysical research communications.

[26]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[27]  P. Geladi.  Notes on the history and nature of partial least squares (PLS) modelling , 1988 .

[28]  C. Dinarello,et al.  Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases , 1991, Current Biology.

[29]  Wei Guo,et al.  Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.

[30]  C. Dominguez,et al.  p38 MAP kinase inhibitors: many are made, but few are chosen. , 2005, Current opinion in drug discovery & development.

[31]  Ravindra G. Kulkarni,et al.  Novel targets for antiinflammatory and antiarthritic agents. , 2006, Current pharmaceutical design.

[32]  Gareth Jones,et al.  A genetic algorithm for flexible molecular overlay and pharmacophore elucidation , 1995, J. Comput. Aided Mol. Des..